Articles

  • 2 months ago | cell.com | Milene Vandal |Adam Institoris |Louise Reveret |Ben Korin |Colin Gunn |Sotaro Hirai | +30 more

    KeywordsAlzheimercerebrovascular functionsexual dimorphismbrain endothelial cellsCD2APreelinAβApoER2/LRP8endothelin-1mural cellsGet full text accessLog in, subscribe or purchase for full access. References1. Schaeffer, S. ∙ Iadecola, C. Revisiting the neurovascular unitNat Neurosci. 2021; 24:1198-12092. Korte, N. ∙ Nortley, R. ∙ Attwell, D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer’s diseaseActa Neuropathol. 2020; 140:793-8103. Yang, A.C. ∙ Vest, R.T. ∙ Kern, F. ...

  • Sep 10, 2024 | bioprocessonline.com | Seulki Lee |Jiyeon Lee |Taeyoen Lim |Jaewoon Kim

    Article | September 10, 2024 By Seulki Lee, Jiyeon Lee, Taeyoen Lim, and Jaewoon Kim, Samsung Biologics Charge variants, resulting from post-translational modifications or chemical degradation, are a significant concern in monoclonal antibody (mAb) development and manufacturing. Shifts in isoelectric point (PI) values can lead to charge heterogeneity, impacting drug efficacy and safety. Controlling charge variants is crucial for regulatory approval and clinical success.

  • Sep 10, 2024 | outsourcedpharma.com | Seulki Lee |Jiyeon Lee |Taeyoen Lim |Jaewoon Kim |Louis Garguilo

    Article | September 10, 2024 By Seulki Lee, Jiyeon Lee, Taeyoen Lim, and Jaewoon Kim, Samsung Biologics Charge variants, resulting from post-translational modifications or chemical degradation, are a significant concern in monoclonal antibody (mAb) development and manufacturing. Shifts in isoelectric point (PI) values can lead to charge heterogeneity, impacting drug efficacy and safety. Controlling charge variants is crucial for regulatory approval and clinical success.

  • Sep 10, 2024 | pharmaceuticalonline.com | Seulki Lee |Jiyeon Lee |Taeyoen Lim |Jaewoon Kim

    Article | September 10, 2024 By Seulki Lee, Jiyeon Lee, Taeyoen Lim, and Jaewoon Kim, Samsung Biologics Charge variants, resulting from post-translational modifications or chemical degradation, are a significant concern in monoclonal antibody (mAb) development and manufacturing. Shifts in isoelectric point (PI) values can lead to charge heterogeneity, impacting drug efficacy and safety. Controlling charge variants is crucial for regulatory approval and clinical success.

  • Aug 9, 2024 | dialnet.unirioja.es | Elizabeth Graue |Jiyeon Lee |Moonjoo Woo

    Ayuda Buscar en la ayuda Buscar en la ayuda How parents make decisions about PreK enrollment M. Elizabeth Graue [1] ; Moonjoo Woo [1] ; Jiyeon Lee [2] [1] University of Wisconsin Madison [2] Oregon State University Localización: Archivos Analíticos de Políticas Educativas=Education Policy Analysis Archives, ISSN-e 1068-2341, Vol. 32, Nº.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →